Regenesance B.v.

Calculating rank

USPTO Granted Patents = 6

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 28

Loading Chart...

4 inventors (with patents filed for the assignee):

Frank Baas (6 out of 6 patents)

Marc A Van Dijk (3 out of 42 patents)

Kees Fluiter (2 out of 2 patents)

4. Valeria Ramaglia (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12194091 - Antibodies that bind human C6 and uses thereof (2025-01-14),

2. 11590222 - Antibodies that bind human C6 and uses thereof (2023-02-28),

3. 10675348 - Antibodies that bind human C6 and uses thereof (2020-06-09),

4. 9089555 - Complement antagonists and uses thereof (2015-07-28),

5. 8703730 - Complement antagonists and uses thereof (2014-04-22),

6. 8703136 - Complement inhibition for improved nerve regeneration (2014-04-22),

Company Overview

Regenesance B.v. is a leading biotechnology company dedicated to developing innovative therapies for regenerative medicine. With a focus on stem cell research and tissue engineering, we aim to revolutionize the healthcare industry and improve patients' lives. Our team of experts is committed to advancing the field of regenerative medicine through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#97 in Amsterdam

#972 in Netherlands

Amsterdam, Netherlands

Regenesance B.v.

Forward Citations = 28

4 inventors:

Frank Baas (6 out of 6 patents)

Marc A Van Dijk (3 out of 42 patents)

Kees Fluiter (2 out of 2 patents)

4. Valeria Ramaglia (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Regenesance B.v.. Retrieved from https://idiyas.com/company/regenesance-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]